Price T Rowe Associates Inc Veracyte, Inc. Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 41,041 shares of VCYT stock, worth $872,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,041

Previous 36,785 11.57%

Holding current value

$872,531

Previous $1.01 Million 10.08%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $89,376 - $123,849	4,256 Added 11.57%	41,041 $910,000
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $128,160 - $186,391	6,499 Added 21.46%	36,785 $1.01 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $77,328 - $103,612	-3,463 Reduced 10.26%	30,286 $677,000
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $43,995 - $56,652	2,099 Added 6.63%	33,749 $860,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $25,560 - $34,639	1,242 Added 4.08%	31,650 $706,000

Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $14,177 - $27,724	-926 Reduced 2.96%	30,408 $722,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $4,940 - $8,314	298 Added 0.96%	31,334 $521,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $39,196 - $74,892	2,537 Added 8.9%	31,036 $618,000
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $109,656 - $212,464	4,998 Added 21.27%	28,499 $786,000
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $301,856 - $449,899	-8,364 Reduced 26.25%	23,501 $968,000
Q3 2021 Nov 15, 2021	BUY	$35.62 - $52.97 $44,916 - $66,795	1,261 Added 4.12%	31,865 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $87,389 - $150,212	2,653 Added 9.49%	30,604 $1.22 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $573,084 - $1.05 Million	12,887 Added 85.55%	27,951 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $489,429 - $932,160	15,064 New	15,064 $737,000

Others Institutions Holding VCYT

# of Institutions

257

Shares Held

81.7M

Call Options Held

43K

Put Options Held

82K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.52B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Veracyte, Inc. Transaction History